Busulfan, etoposide, cytarabine, and melphalan
Sponsors
Seoul National University Hospital
Conditions
Non-Hodgkin Lymphoma
Phase 2
Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma
NCT01178658
Start: 2010-07-31Target: 42Updated: 2014-08-25
Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma
NCT01178645
Start: 2010-07-31Target: 42Updated: 2014-08-25